Skip to main content

Table 2 Clinical outcomes of patients with spontaneous bacterial peritonitis (SBP) due to Escherichia coli and Klebsiella species (EK), according to the production of extended-spectrum β-lactamase (ESBL)

From: Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiellaspecies: A retrospective matched case-control study

Outcomes

SBP due to

P-value

 

ESBL-EK (n = 26)

Non-ESBL-EK (n = 78)

 

Initial response

   

   Complete response (n, %)

2 (8%)

28 (36%)

< 0.001

   Treatment failure (n, %)

15 (58%)

10 (13%)

0.006

7-day mortality (n, %)

9 (35%)

3 (4%)

< 0.001

30-day mortality (n, %)

12 (46%)

11 (14%)

0.001

  1. Initial response was assessed 72 hours after the initiation of empirical treatment